N., Chandrashekar, C., Karthik, Y., Vasantha, G
How Payer Friction and Patient Drop-Off Undermine Obesity GLP-1 Uptake The GLP-1 market is experiencing unprecedented demand, yet despite its clinical promise for obesity, diabetes, and other conditions, patient behavior and friction throughout the treatment journey continue to erode its commercial potential
Recent reports indicate that high blood insulin levels exacerbate acne (181)
With 50% less sodium, significantly less fat, and barely any refined carbohydrates, this breakfast bake is gentler on your digestive system while still satisfying those comfort food cravings
SGLT2 [sodium-glucose cotransporter 2] inhibitors initially seemed to be linked with an even lower risk of uveitis compared to GLP-1 receptor agonists, but after doing a sensitivity analysis of patients on monotherapy, we no longer found that association
Eventually this excess debris can lead to cell death